UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date
of
Report (Date of earliest event reported) October
17, 2007
Interpharm
Holdings, Inc.
(Exact
name of Registrant as specified in charter)
|
Delaware
|
0-22710
|
13-3673965
|
|
(State
or other jurisdic-
|
(Commission
|
(IRS
Employer
|
|
tion
of incorporation)
|
File
Number)
|
Identification
No.)
|
|
|
11788
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant's
telephone number, including area code: (631)
952 0214
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
Written
communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting
material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement
communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))
o Pre-commencement
communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Items
3.01 and 8.01 Notice
of Failure to Satisfy a Continued Listing Rule and Other
Events
In
its
Current Report on Form 8-K and Form 8-K/A filed with the SEC on October 12
and
15, 2007, respectively, Interpharm Holdings, Inc. (“Holdings”) disclosed that as
a result of negotiations with Wells Fargo Bank, National Association, acting
through its Wells Fargo Business Credit operating division ("Wells Fargo"),
Holdings would not be able to file its Form 10-K by its due date of October
15,
2007 and anticipates filing upon the conclusion of negotiations with Wells
Fargo. Holdings further disclosed that on October 12, 2007, Holdings notified
the American Stock Exchange (“AMEX”) that it would not file its Form 10-K in a
timely manner in conformity with Section 610(b) of the AMEX Company
Guide.
On
October 15, 2007, Holdings received notice from the AMEX that trading in its
common stock would be halted pending compliance with AMEX rules through the
filing of financial information.
On
October 16, 2007, Holdings received a notice from the AMEX Listing Qualification
Department that it must file its Annual Report on Form 10-K as required by
Sections 134 and 1101 of the AMEX Company Guide in order to maintain its AMEX
listing. As previously disclosed, Holdings plans to file its Annual Report
on
Form 10-K at the conclusion of its negotiations with Wells Fargo.
Item
9.01 Financial
Statements and Exhibits
| Exhibit 99.1 |
Press release, dated October 17,
2007. |
Signatures
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
INTERPHARM
HOLDINGS, INC.
|
| |
|
|
|
October
17, 2007
|
By:
|
/s/
Peter Giallorenzo.
|
| |
|
Peter
Giallorenzo
|
| |
|
Chief
Financial Officer and
|
| |
|
Chief
Operating Officer
|